Ami Bavishi | Director of Investor Relations |
Vicente Anido | Chief Executive Officer |
Thomas Mitro | President and Chief Operating Officer |
Richard Rubino | Chief Financial Officer |
Annabel Samimy | Stifel, Nicolaus & Company |
Kenneth Cacciatore | Cowen and Company |
Serge Belanger | Needham & Company |
Esther Rajavelu | Oppenheimer & Co. Inc. |
Gregory Fraser | SunTrust Robinson Humphrey, Inc. |
Joseph Catanzaro | Piper Sandler Companies |
Jennifer Kim | Cantor Fitzgerald |
Jason Gerberry | Bank of America Merrill Lynch |
Difei Yang | Mizuho Securities |
Elliot Wilbur | Raymond James |
Good afternoon, ladies and gentlemen. Thank you for standing by. And welcome to the Aerie Pharmaceuticals Fourth Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.